As reported by Reuters, The Access to Medicines Index (AMI) has announced that European pharmaceutical companies still outrank their U.S rivals in providing drugs to developing countries. They established the lead 2 years ago, however, signs indicate that the gap may well be shrinking.
The global pharmaceutical company, GlaxoSmithKline (GSK) was ranked first in the list of top pharma companies which set out to ensure drugs are made available to the poor. Following GSK came the U.S pharmaceutical company Merck & Co., Switzerland’s Novartis, U.S based Gilead Sciences and France’s Sanofi–Aventis. The AMI is designed to give investors a way of comparing companies social responsibility.
Looking for a job in the pharmaceutical industry? Click here to search our current pharmaceutical jobs now.